Get startedLog in
    Picture of Edding Genor group logo

    6998 — Edding Genor group News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapValue Trap
    All News

    Brief: Jhbp Cy To Launch Of Phase I/II Clinical Trial Of Gb261 In China

    Picture of Edding Genor group logoEdding Genor group
    08/09/2022 15:35
    Sept 8 (Reuters) - Genor Biopharma Holdings Ltd  6998.HK :
    * LAUNCH OF PHASE I/II CLINICAL TRIAL OF GB261 IN CHINA

Further company coverage:  6998.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Edding Genor group

    See all news